Pharmacogenetics of Naltrexone for Stimulant Abuse

Clinical trial NCT03226223 · COMPLETED

Trial details

NCT number: NCT03226223
Sponsor: New York State Psychiatric Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Substance Use Disorders Methamphetamine Abuse

Start date: 2016-09-15
Primary completion: 2019-07-15
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.